DIM
LAB icon

DLK Investment Management’s Standard BioTools LAB Stock Holding History

DLK Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,380
Closed -$10.5K – 112
2026
Q1 		$10.5K Hold
11,380
– – ﹤0.01% 90
2025
Q4 		$14.6K Hold
11,380
– – 0.01% 88
2025
Q3 		$14.8K Hold
11,380
– – 0.01% 89
2025
Q2 		$13.7K Buy
+11,380
New +$12.6K 0.01% 88

Other funds holding LAB

MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM

DLK Investment Management's LAB Position: Q2 2026 in Review

DLK Investment Management sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 11,380 shares — an estimated $10.5K sold.

DLK Investment Management first reported a position in LAB in Q2 2025 and held it in 4 quarters. The position peaked at $14.8K in Q3 2025. 13 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • DLK Investment Management reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • DLK Investment Management sold 11,380 Standard BioTools shares in Q2 2026, an estimated $10.5K.
  • DLK Investment Management first reported a position in Standard BioTools in Q2 2025 and held it in 4 quarters.
  • DLK Investment Management's Standard BioTools position peaked at $14.8K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.